Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
CAMP4 Therapeutics Announces Dosing of First Participant in Phase 1 Clinical Study of CMP-CPS-001, a Potential First-in-Class Therapeutic for Urea Cycle Disorders
Read Article
News
2024
2023
Archive
Search news articles
June 8, 2023
Inipharm’s Development Candidate INI-822 Shows Improvements in Markers of Liver Homeostasis in Preclinical Studies
June 8, 2023
Escient Pharmaceuticals Announces Presentation Of Data Demonstrating Efficacy Of EP262 In Inhibition Of Mast Cell Degranulation In Multiple Species At The European Academy Of Allergy And Clinical Immunology
June 8, 2023
Pinnacle Fertility Partners With TMRW Life Sciences to Adopt State-of-the-Art Technology for the Safe Management & Storage of Frozen Eggs & Embryos
June 8, 2023
Arvinas Announces Interim Data from the ARV-766 Phase 1/2 Dose Escalation and Expansion Trial Showing Promising Signals of Efficacy in Late-line mCRPC, Including in Patients with AR L702H Mutations
May 16, 2023
IDEAYA Expands Clinical Trial Collaboration and Supply Agreements with Pfizer to Support Registrational Trial Evaluating Darovasertib and Crizotinib Combination in First-Line Metastatic Uveal Melanoma
May 16, 2023
Homology Medicines Announces First Data from IND-Enabling Studies with GTx-mAb Candidate HMI-104 for PNH, Which Demonstrated Sustained Expression of Functional C5mAb Levels, at the ASGCT Annual Meeting
May 16, 2023
Nido Biosciences Emerges as Clinical Stage Company Raising $109 Million to Advance Treatments for Debilitating Neurological Diseases
May 16, 2023
Ensoma Closes Series B Extension, Bringing Total Round to $135 Million
May 10, 2023
Impel Pharmaceuticals Announces Appointment of Michael W. Kalb as Chief Financial Officer
May 4, 2023
Cidara Therapeutics Presents New Preclinical Data on Novel Drug-Fc Conjugate CD388 at the 7th International Society for Influenza and Other Respiratory Virus Diseases Conference
« Previous Page
1
…
7
8
9
10
11
…
118
Next Page »